nobel prize glp 1 Joel Habener Receives Breakthrough in Life Sciences for Contributions to GLP-1 Medications 5 Nobel-worthy discoveries that haven't

they facilitate weight loss and the decrease of body fat

Should Medicare and Medicaid expand to cover weight loss drugs

With the participation of researchers from the Paul Langerhans Institute Dresden (PLID), partner at the German Center for Diabetes Research, a GLP-1 receptor agonist in the form of tablets could for the first time be compared with the most common second-line therapy of T2D, a DPP-IV inhibitor

7 easy food swaps that add 5863g protein and save 610680 calories on GLP-1

It is a major therapeutic target for type 2 diabetes and obesity

Novo Nordisk, Eli Lilly, Pfizer, Amgen and others are all competing to develop stronger and more convenient weight loss drugs